BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36500629)

  • 1. Continuous-Flow Chemistry and Photochemistry for Manufacturing of Active Pharmaceutical Ingredients.
    Horáková P; Kočí K
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of continuous flow chemistry in the synthesis of natural products and active pharmaceutical ingredients.
    Souza JM; Galaverna R; Souza AAN; Brocksom TJ; Pastre JC; Souza ROMA; Oliveira KT
    An Acad Bras Cienc; 2018; 90(1 Suppl 2):1131-1174. PubMed ID: 29873673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous low-dose feeding of highly active pharmaceutical ingredients in hot-melt extrusion.
    Llusa M; Mohr S; Baumgartner R; Paudel A; Koscher G; Khinast J
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1360-4. PubMed ID: 26755129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The route from problem to solution in multistep continuous flow synthesis of pharmaceutical compounds.
    Bana P; Örkényi R; Lövei K; Lakó Á; Túrós GI; Éles J; Faigl F; Greiner I
    Bioorg Med Chem; 2017 Dec; 25(23):6180-6189. PubMed ID: 28087127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Novel Continuous Filtration Unit for Pharmaceutical Process Development and Manufacturing.
    Ottoboni S; Price CJ; Steven C; Meehan E; Barton A; Firth P; Mitchell A; Tahir F
    J Pharm Sci; 2019 Jan; 108(1):372-381. PubMed ID: 30009797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients.
    Malwade CR; Qu H
    Curr Pharm Des; 2018; 24(21):2456-2472. PubMed ID: 29956616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
    Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
    Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.
    Cole KP; Johnson MD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):5-13. PubMed ID: 29206489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical Industry.
    Schenck L; Risteen B; Johnson LM; Koynov A; Bonaga L; Orr R; Hancock B
    J Pharm Sci; 2024 Feb; 113(2):306-313. PubMed ID: 38065243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-flow technology—a tool for the safe manufacturing of active pharmaceutical ingredients.
    Gutmann B; Cantillo D; Kappe CO
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6688-728. PubMed ID: 25989203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing active pharmaceutical ingredient raw material variability during twin-screw blend feeding.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Schubert MA; Vervaet C; De Beer T
    Eur J Pharm Biopharm; 2019 Feb; 135():49-60. PubMed ID: 30582959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing.
    Burcham CL; Florence AJ; Johnson MD
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():253-281. PubMed ID: 29879381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
    Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
    Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared spectroscopic applications in pharmaceutical particle technology.
    Razuc M; Grafia A; Gallo L; Ramírez-Rigo MV; Romañach RJ
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1565-1589. PubMed ID: 31282753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.